Publication: Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure.
Loading...
Identifiers
Date
2022-01-02
Authors
Rúa-Figueroa, Iñigo
Rúa-Figueroa, David
Pérez-Veiga, Natalia
Anzola, Ana M
Galindo-Izquierdo, María
Calvo-Alén, Jaime
Fernández-Nebro, Antonio
Sangüesa, Clara
Menor-Almagro, Raúl
Tomero, Eva
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Factors associated with chronic heart failure (CHF) in patients with systemic lupus erythematosus (SLE) have received little attention. Recent data on the use of hydroxychloroquine in the treatment of SARS-CoV-2 infection have cast doubt on its cardiac safety. The factors associated with CHF, including therapy with antimalarials, were analyzed in a large multicenter SLE cohort. Cross-sectional study including all patients with SLE (ACR-1997 criteria) included in the Spanish Society of Rheumatology Lupus Register (RELESSER), based on historically gathered data. Patients with CHF prior to diagnosis of SLE were excluded. A multivariable analysis exploring factors associated with CHF was conducted. The study population comprised 117 patients with SLE (ACR-97 criteria) and CHF and 3,506 SLE controls. Ninety percent were women. Patients with CHF were older and presented greater SLE severity, organ damage, and mortality than those without CHF. The multivariable model revealed the factors associated with CHF to be ischemic heart disease (7.96 [4.01-15.48], p Patients with SLE and CHF experience more severe SLE. Treatment with antimalarials appears to confer a cardioprotective effect.
Description
MeSH Terms
Antimalarials
COVID-19
Cross-Sectional Studies
Female
Heart Failure
Humans
Lupus Erythematosus, Systemic
Registries
Rheumatology
SARS-CoV-2
COVID-19
Cross-Sectional Studies
Female
Heart Failure
Humans
Lupus Erythematosus, Systemic
Registries
Rheumatology
SARS-CoV-2
DeCS Terms
CIE Terms
Keywords
Antimalarials, Chronic heart failure, Systemic lupus erythematosus